Who
Scott T. Garrett
Director
Company insider
Files Form 4 as: Director, HCW Biologics; Director, Hologic; CEO & President, Beckman Coulter.
In numbers
- Trades disclosed
- 211
- Buys
- 5
- Sells
- 3
- Bought
- $1.8M
- Sold
- $2.7M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 4 Jan 2006
- Last trade
- 29 Jul 2026
- Last filed
- 31 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Jul 2026filed 31 Jul 2026 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $20K7,736 at $2.59 | filing |
| 29 Jul 2026filed 31 Jul 2026 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $20K7,736 at $2.59 | filing |
| 22 May 2026filed 27 May 2026 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $250K177,936 at $1.41 | filing |
| 22 May 2026filed 27 May 2026 | HCWB HCW Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code P | —177,936 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | HCWB HCW Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code P | —177,936 at $0.00 | filing |
| 22 May 2026filed 27 May 2026 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $251K177,936 at $1.41 | filing |
| 16 May 2025filed 20 May 2025 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $100K13,423 at $7.45 | filing |
| 8 May 2025filed 9 May 2025 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Bought | $140K5,385 at $26.00 | filing |
| 7 May 2025filed 9 May 2025 | HCWB HCW Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code P | —2,692 at $0.00 | filing |
| 14 Jun 2024filed 17 Jun 2024 | HCWB HCW Biologicsoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 14 Mar 2024filed 15 Mar 2024 | Hologicoption or derivative | SEC FORM 4 Code M | —9,039 at $0.00 | filing |
| 14 Mar 2024filed 15 Mar 2024 | Hologicoption or derivative | SEC FORM 4 Code M | —7,402 at $0.00 | filing |
| 14 Mar 2024filed 15 Mar 2024 | Hologic | SEC FORM 4 Code M | $242K9,039 at $26.74 | filing |
| 14 Mar 2024filed 15 Mar 2024 | Hologic | SEC FORM 4 Code M | $267K7,402 at $36.04 | filing |
| 14 Mar 2024filed 15 Mar 2024 | Hologic | SEC FORM 4 Sold | $1.2M16,441 at $75.50 | filing |
| 7 Mar 2024filed 11 Mar 2024 | Hologicoption or derivative | SEC FORM 4 Code A | —4,536 at $0.00 | filing |
| 7 Mar 2024filed 11 Mar 2024 | Hologic | SEC FORM 4 Code A | —1,572 | filing |
| 20 Feb 2024filed 22 Feb 2024 | HCWB HCW BiologicsBiotechnology | SEC FORM 4 Code A | $200K142,858 at $1.40 | filing |
| 11 Dec 2023filed 13 Dec 2023 | Hologic | SEC FORM 4 Sold | $687K10,000 at $68.71 | filing |
| 15 Jun 2023filed 20 Jun 2023 | Hologic | SEC FORM 4 Sold | $797K10,000 at $79.72 | filing |
News
Financial Survey: HCW Biologics (NASDAQ:HCWB) vs. Cardio Diagnostics (NASDAQ:CDIO)HCWB · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name Scott T. Garrett; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.